Bath & Body Works, Inc.’s Stock Price Dips to $27.54, Shedding 3.67% in Latest Market Review

Bath & Body Works, Inc. (BBWI)

27.54 USD -1.05 (-3.67%) Volume: 6.59M

Bath & Body Works, Inc.’s stock price stands at 27.54 USD, witnessing a decline of -3.67% this trading session with a trading volume of 6.59M, reflecting a significant YTD decrease of -36.19%, indicating a challenging market performance.

Latest developments on Bath & Body Works, Inc.

Today, Bath & Body Works (BBWI) stock price experienced significant movements following their latest financial report. According to Jim Cramer, the company ‘Reported Another Bad Quarter’, which likely contributed to the fluctuations in their stock price. Investors are closely monitoring the situation as they assess the impacts of this news on the company’s overall performance and future prospects. Stay tuned for more updates on Bath & Body Works stock as the situation continues to develop.

A look at Bath & Body Works, Inc. Smart Scores

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Based on the Smartkarma Smart Scores, Bath & Body Works has a positive long-term outlook. With high scores in Dividend and Resilience, the company is positioned well to weather economic uncertainties and provide returns to shareholders. Additionally, its moderate score in Growth indicates potential for expansion and development in the future. However, the lower score in Momentum suggests that the company may face challenges in maintaining its current pace of growth.

Bath & Body Works, Inc. is a manufacturer of personal care products, offering a range of fragrance, body care, and bath products to customers globally. With a strong emphasis on dividends and resilience, the company demonstrates stability and commitment to its shareholders. While there is room for growth, the company may need to address factors affecting its momentum to sustain its position in the market in the long term.

Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.

💡 Before it’s here, it’s on Smartkarma